CogniStem (Amniotics)

N/A

Report date: 2024/03/14 18:32:18

Base Information

Drug NameCogniStem (Amniotics)
Drug Alias NameCNS specific amniotic mesenchymal stem cell therapy (Amniotics)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsNeurodegenerative DiseasesAmyotrophic Lateral SclerosisAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmniotics AB
China Registration ClassN/A

Develop Information

Active CompaniesAmniotics AB
Inactive CompaniesN/A
Active IndicationsNeurodegenerative DiseasesAmyotrophic Lateral SclerosisAlzheimer Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A